Ocular Therapeutix, Inc. Tech Stack

Ocular Therapeutix, Inc. uses 8 technology products and services including SAS, Veeva Systems CRM, SAP S/4HANA, and more. Explore Ocular Therapeutix, Inc.'s tech stack below.

SAS

Business Intelligence

Veeva Systems CRM

Customer Relationship Management

SAP S/4HANA

Enterprise Resource Planning

ADP

Human Resource Management System

OWL Carousel

Javascript Libraries

Microsoft Project

Project Management

Animate.css

UI Frameworks

Minitab

Visualisation Software

Ocular Therapeutix, Inc. Email Formats	Example	Percentage
FLast@ocutx.com	JDoe@ocutx.com	95%
Last@ocutx.com	Doe@ocutx.com	4%
FL@ocutx.com	JD@ocutx.com	1%

Ocular Therapeutix, Inc. Email Formats

Example

Percentage

FLast@ocutx.com

JDoe@ocutx.com

95%

Last@ocutx.com

Doe@ocutx.com

FL@ocutx.com

JD@ocutx.com

Frequently Asked Questions

Where is Ocular Therapeutix, Inc.'s headquarters located?

Ocular Therapeutix, Inc.'s main headquarters is located at 15 Crosby Drive Bedford, Massachusetts 01730 United States. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Ocular Therapeutix, Inc.'s phone number?

You can contact Ocular Therapeutix, Inc.'s main corporate office by phone at

+1-781-357-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ocular Therapeutix, Inc.'s stock symbol?

Ocular Therapeutix, Inc. is a publicly traded company; the company's stock symbol is OCUL.

What is Ocular Therapeutix, Inc.'s official website and social media links?

Ocular Therapeutix, Inc.'s official website is ocutx.com and has social profiles on LinkedIn Crunchbase.

What is Ocular Therapeutix, Inc.'s NAICS code?

Ocular Therapeutix, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Ocular Therapeutix, Inc. have currently?

As of June 2026, Ocular Therapeutix, Inc. has approximately 348 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Human Resources Officer: B. R.Chief Business Officer: N. S.Chief Commercial Officer: S. M.. Explore Ocular Therapeutix, Inc.'s employee directory with LeadIQ.

What industry does Ocular Therapeutix, Inc. belong to?

Ocular Therapeutix, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Ocular Therapeutix, Inc. use?

Ocular Therapeutix, Inc.'s tech stack includes SASVeeva Systems CRMSAP S/4HANAADPOWL CarouselMicrosoft ProjectAnimate.cssMinitab.

What is Ocular Therapeutix, Inc.'s email format?

Ocular Therapeutix, Inc.'s email format typically follows the pattern of FLast@ocutx.com. Find more Ocular Therapeutix, Inc. email formats with LeadIQ.

When was Ocular Therapeutix, Inc. founded?

Ocular Therapeutix, Inc. was founded in 2006.

Ocular Therapeutix, Inc.

Q: What is Ocular Therapeutix, Inc.'s official website and social media links?

Ocular Therapeutix, Inc.'s official website is ocutx.com. Ocular Therapeutix, Inc. has social profiles on LinkedIn.

Q: How many employees does Ocular Therapeutix, Inc. have currently?

Ocular Therapeutix, Inc. has approximately 348 employees.

Q: What technology does Ocular Therapeutix, Inc. use?

Ocular Therapeutix, Inc.'s tech stack includes Gravity Forms, Microsoft Word, Acquia Cloud Platform, iCIMS, Adobe Photoshop.

Q: What is Ocular Therapeutix, Inc.'s NAICS code?

Ocular Therapeutix, Inc.'s NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingMassachusetts, United States201-500 Employees

Based in Bedford, Massachusetts, Ocular Therapeutix is a biopharmaceutical company focused on retinal disease and the development of therapies to improve treatment outcomes. Its lead candidate, AXPAXLI (OTX-TKI), is a hydrogel formulation of axitinib delivered by intravitreal injection, developed using the ELUTYX platform. AXPAXLI is in Phase 3 trials for wet age-related macular degeneration and is being explored for other retinal conditions such as NPDR and diabetic macular edema. The company operates with a mid-sized workforce and serves the ophthalmic therapeutic area. In 2026 it announced participation at Summit 2026, while also facing a lawsuit from EyePoint Pharmaceuticals alleging defamation and related claims.

Insights

Similar companies to Ocular Therapeutix, Inc.

Immunocore

Omeros Corporation